trabectedin · Medicine question

For which type of ovarian cancer is trabectedin (Yondelis) indicated in combination with pegylated liposomal doxorubicin?

Name: For which type of ovarian cancer is trabectedin (Yondelis) indicated in combination with pegylated liposomal doxorubicin?
Published: 2026-11-08T02:04:24.100Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Trabectedin (Yondelis), in combination with pegylated liposomal doxorubicin, is indicated for relapsed platinum-sensitive ovarian cancer.

Sources for this answer

Yondelis 0.25 mg powder for concentrate for solution for infusionImmedica · emc · SmPC §4.1 Therapeutic Indications · Version 23Document updated 1 October 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about trabectedin